Gram-negative bacterial molecules associate with Alzheimer disease pathology

Neurology

Volumn 87, Issue 22, 2016, Pages 2324-2332

  Zhan, Xinhua ^a   Stamova, Boryana ^a   Jin, Lee Way ^a   Decarli, Charles ^a   Phinney, Brett ^a   Sharp, Frank R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; LIPOPOLYSACCHARIDE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); BACTERIAL DNA; ESCHERICHIA COLI PROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA CONTAMINATION; DNA SEQUENCE; EPENDYMA CELL; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROCYTE PROGENITOR; OLIGODENDROGLIA; PRIORITY JOURNAL; WESTERN BLOTTING; WHITE MATTER; AGED; BRAIN; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MICROBIOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOTTING, WESTERN; BRAIN; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAY MATTER; HUMANS; LIPOPOLYSACCHARIDES; MALE; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; WHITE MATTER;

EID: 84999863217     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003391     Document Type: Article

References (30)

1. Holmes C, Butchart J. Systemic inflammation and Alzheimer's disease. Biochem Soc Trans 2011;39:898-901.
2. Dunn N, Mullee M, Perry VH, Holmes C. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord 2005; 19:91-94.
3. Tyas SL, Manfreda J, Strain LA, Montgomery PR. Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol 2001; 30:590-597.
4. Verreault R, Laurin D, Lindsay J, De Serres G. Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ 2001;165:1495-1498.
5. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004;61:668-672.
6. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol 2002;52:168-174.
7. Imbimbo BP. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Expert Opin Investig Drugs 2009;18:1147-1168.
8. Vlad SC, Miller DR, Kowall NW, Felson DT. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008;70:1672-1677.
9. Bibi F, Yasir M, Sohrab SS, et al. Link between chronic bacterial inflammation and Alzheimer disease. CNS Neurol Disord Drug Targets 2014;13:1140-1147.
10. Singhrao SK, Harding A, Poole S, Kesavalu L, Crean S. Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer's disease. Mediators Inflamm 2015;2015:137357.
11. Noble JM, Scarmeas N, Celenti RS, et al. Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease. PLoS One 2014;9:e114959.
12. Civitelli L, Marcocci ME, Celestino I, et al. Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer's disease pathogenesis. J Neurovirol 2015;21:480-490.
13. Chapman MR, Robinson LS, Pinkner JS, et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 2002;295:851-855.
14. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid: from bacteria to humans. Trends Biochem Sci 2007;32:217-224.
15. Zhan X, Cox C, Ander BP, et al. Inflammation combined with ischemia produces myelin injury and plaque-like aggregates of myelin, amyloid-beta and AbetaPP in adult rat brain. J Alzheimers Dis 2015;46:507-523.
16. Branton WG, Ellestad KK, Maingat F, et al. Brain microbial populations in HIV/AIDS: alpha-proteobacteria predominate independent of host immune status. PLoS One 2013;8:e54673.
17. Zhan X, Jickling GC, Ander BP, et al. Myelin injury and degraded myelin vesicles in Alzheimer's disease. Curr Alzheimer Res 2014;11:232-238.
18. Zhan X, Jickling GC, Ander BP, et al. Myelin basic protein associates with AbetaPP, Abeta1-42, and amyloid plaques in cortex of Alzheimer's disease brain. J Alzheimers Dis 2015;44:1213-1229.
19. Quinones B, SwimleyMS, Narm KE, Patel RN, Cooley MB, Mandrell RE. O-antigen and virulence profiling of shiga toxin-producing Escherichia coli by a rapid and costeffective DNA microarray colorimetric method. Front Cell Infect Microbiol 2012;2:61.
20. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18:351-357.
21. Klemm P, Schembri MA. Bacterial adhesins: function and structure. International journal of medical microbiology. Int J Med Microbiol 2000;290:27-35.
22. Schrijver IA, van Meurs M, Melief MJ, et al. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 2001;124: 1544-1554.
23. Visser L, Melief MJ, van Riel D, et al. Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol 2006;169:1671-1685.
24. Fischer Walker CL, Sack D, Black RE. Etiology of diarrhea in older children, adolescents and adults: a systematic review. PLoS Negl Trop Dis 2010;4:e768.
25. Nagy B, Fekete PZ. Enterotoxigenic Escherichia coli (ETEC) in farm animals. Vet Res 1999;30:259-284.
26. Schmidt C. Mental health: thinking from the gut. Nature 2015;518:S12-S15.
27. Khan TK, Alkon DL. Peripheral biomarkers of Alzheimer's disease. J Alzheimers Dis 2015;44:729-744.
28. Erickson MA, Hartvigson PE, Morofuji Y, Owen JB, Butterfield DA, Banks WA. Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation 2012;9:150.
29. Janota C, Lemere CA, Brito MA. Dissecting the contribution of vascular Alterations and aging to Alzheimer's disease. Mol Neurobiol 2015;53:3793-3811.
30. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 2004;25:843-851.